Lifestyle biomarkers investigated in prostate cancer survivors

19:00 EST 9 Jan 2018 | AAAS

(Medical University of South Carolina) Hollings Cancer Center at the Medical University of South Carolina, in collaboration with South Carolina State University, opened a clinical trial in Jan. 2018 to investigate the role of lifestyle factors on advanced glycation end products and disease recurrence in prostate cancer survivors. The trial aims to determine whether a decrease in advanced glycation end products through dietary and exercise intervention can improve quality of life and decrease tumor recurrence in these patients.

Original Article: Lifestyle biomarkers investigated in prostate cancer survivors


More From BioPortfolio on "Lifestyle biomarkers investigated in prostate cancer survivors"

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...